| [1] Singleton A B, Farrer M, Johnson J, et al. Alpha-Synuclein locus triplication causes Parkinson’s Disease [J]. Science, 2003, 302(5646): 841.[2] Zarranz J J, Alegre J, Gomez-Esteban J C, et al. The new mutation, E46K, of alpha-Synuclein causes Parkinson and Lewy body dementia [J]. Ann Neurol, 2004, 55(2): 164-173.[3] Greffard S, Verny M, Bonnet A M, et al. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death [J]. Neurobiol Aging, 2010, 31(1): 99-103.[4] Cuervo A M, Stefanis L, Fredenburg R, et al. Impaired degradation of mutant alpha-Synuclein by chaperone-mediated autophagy [J]. Science, 2004, 305(5688): 1292-1295.[5] Shin Y, Klucken J, Patterson C, et al. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-Synuclein degradation decisions between proteasomal and lysosomal pathways [J]. J Biol Chem, 2005, 280(25): 23727-23734.[6] Orenstein S J, Cuervo A M. Chaperone-mediated autophagy: Molecular mechanisms and physiological relevance [J]. Semin Cell Dev Biol, 2010, 21(7): 719-726.[7] Cookson M R. A feedforward loop links gaucher and parkinson’s diseases [J]. Cell, 2011, 146(1): 9-11.[8] Xilouri M, Vogiatzi T, Vekrellis K, et al. Alpha-Synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis [J]. Autophagy, 2008, 4(7): 917-919.[9] Xu Y H, Sun Y, Ran H, et al. Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models [J]. Mol Genet Metab, 2011, 102(4): 436-447.[10] Mazzulli J R, Xu Y H, Sun Y, et al. Gaucher disease glucocerebrosidase and α-Synuclein form a bidirectional pathogenic loop in synucleinopathies [J]. Cell, 2011, 146(1): 37-52.[11] Liu G, Zhang C, Yin J, et al. α-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down regulates complex I activity [J]. Neurosci Lett, 2009, 454(3): 187-192.[12] Yu S, Li X, Liu G, et al. Extensive nuclear localization of alpha-Synuclein in normal rat brain neurons revealed by a novel monoclonal antibody [J]. Neuroscience, 2007, 145(2): 539-555.[13] Choi J H, Stubblefield B, Cookson M R, et al. Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations [J]. Mol Genet Metab, 2011, 104(1-2): 185-188.[14] Bekris LM, Mata I F, Zabetian C P. The genetics of parkinson disease [J]. J Geriatr Psychiatry Neurol, 2010, 23(4): 228-242.[15] Manning-Bog A B, Schule B, Langston J W. Alpha-Synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and Parkinsonism [J]. Neurotoxicology, 2009, 30(6): 1127-1132.[16] DePaolo J, Goker-Alpan O, Samaddar T, et al. The association between mutations in the lysosomal protein glucocerebrosidase and Parkinsonism [J]. Mov Disord, 2009, 24(11): 1571-1578.[17] Kirkitadze M D, Bitan G, Teplow D B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies [J]. J Neurosci Res, 2002, 69(5): 567-577. |
